Screening of infectious microorganisms in blood banks in Douala (1995-2004);Détection des agents infectieux dans les banques de sang de Douala (1995-2004)

Cahiers Sante

Volumn 19, Issue 1, 2009, Pages 3-8

  Mogtomo, Martin Luther Koanga ^a   Fomekong, Sylvie Louandji ^a   Kuate, Honoré Fotso ^a   Ngane, Annie Ngono ^a  

^a UNIVERSITY OF DOUALA   (Cameroon)

Author keywords

Blood transfusion; HBV; HCV; HIV; Plasmodium falciparum; Syphilis

Indexed keywords

EID: 70350316105     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: 10.1684/san.2009.0144     Document Type: Article

References (23)

1. Schmunis GA, Zinker F, Pinnheiro F, Brandling-Bennett D. Risk of transfusion transmitted infectious disease in Central and South America. Emer Infec Dis 1998; 4: 5-11.
2. Lackritz EM, Satten GA, Aberle-Grasse J. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United State. N Eng J Med 1995; 333: 1721-5.
3. Screiber GB, Busch MP, Kleinman SH, Kore-litz JJ. The risk of transfusion-transmitted viral infections. N Eng J Med 1996; 334: 1685-90.
4. Bush MP. Incidence of infectious disease markers in blood donors, implications for resi-dual risk of viral transmission by transfusion. Program and abstract of the National Institutes of Health Development Conference. January 9-111995, Bethesda (MD); National Institutes of Health.
5. Pan American Health Organization. Blood bank situation in Latin America in 1996: sero-logical markers for communicable diseases in blood donors. Epidemiol Bull 1998; 19: 12-4.
6. Third Meeting of the task Force on surveillance for Emerging and Re-Emerging Infectious diseases. 16-17 November 1998, Mexico city, Mexico, PAHO/HCP/HCT/141/99.
7. Jolivet-reynaud C, Lesenechal M, O'Donnel B. Localization of hepatite B surface antigen epitopes present on variants and specifically recognised by anti-hepatite B surface antigen monoclonal antibodies. J Med Virol 2001; 65: 241-9.
8. Aldershvile J, Frösner GG, Neilsen JO. Hepatite B antigen and antibody measured by radio-immunoassy in acute hepatitis B surface anti-gen positive hepatitis. J Inf Diseases 1980; 141: 293-8.
9. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. Identification of an immunodominant epitope within the capsid protein of hepatis C virus. Proc Natl Acad Sci USA 1991; 88: 5462-6.
10. Ching WM, Wychowsky C, Beach MJ, et al. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatis C virus. Proc Natl Acad Sci USA 1992; 89: 3190-4.
11. Couruce AM, Le Marrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients under-going hemodialysis: comparison of second and third generation anti-HCV assays. Transfusion 1994; 34: 790-5.
12. Deguchi M, Hosotsubo H, Izumi Y, Ohmine T, Amino N, Miyai K. Measurement of antitreponema pallidium antibodies using a new artificial carrier, high-density composite parti-cles (HDP). Medicine and Pharmacy 1991; 26: 333-9.
13. Farshy CE, Hunter EF, Larsen SA, Cerny EH. Double-conjugate enzyme-linked immunosor-bent assay for immunoglobulins G and M against Treponema pallidum. J Clin Microbiol 1984; 20: 1109-13.
14. Organisation mondiale de la sante ́ (OMS), Division de la lutte contre les maladies; Degu-chi M, Hosotsubo H, Asari S, Yamashita N, Ohmine T, Amino N. 1993. Measurement of anti-Treponema pallidium antibodies by the indirect agglutination reaction and clinical application. Jarman.tropicales: évaluation dérapeutique des antipaludiques pour le traitement du paludisme à Plasmo-dium falciparum non compliqué. WHO/MAL 96. Genève: OMS, 1993.
15. Janot C, Courouge AM. Les risques de la transfusion. La recherche 1993; 254: 618-23.
16. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody - positive blood donations. Ann Intern Med 1990; 113: 733-9.
17. Uttendaelle S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third generation screening and confirmatory assay for HCV antibodies. Vox Sang 1994; 66: 122-9.
18. Vrielink H, Reesink PJ, Van den Burg PJM, et al. Performance of three generation of anti-hepatitis C virus enzyme-linked immunosor-bent assays in donors and patients. Transfusion 1997; 37: 847-9.
19. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first-and second-generation assays. N Engl J Med 1991; 325: 1325-9.
20. Monteux F, Bouquillon J, Mbass JR, Auren-che, Guévart E. Urgence transfusionnelle et risque VIH en milieu rural du Nord Cameroun. Med Trop 2002; 62: 283.
21. Guiguemde TR, Sanou MA, Ouedrago JB, Coulibaly N, Ghary AR, Coulibaly SO. Le palu-disme et la transfusion, une e ́tude portant sur les donneurs de la banque de sang de l'hoˆpital de Bobo-Dioulasso (Burkina Faso). Malaria 1995; 2: 35-8.
22. Kinde G, Oke J, Gnahoui I, Massoughodji A. Le risque de paludisme transfusionnel àCotonou, Bénin. Santé 1998; 10: 389-92.
23. o 2004/014 du 22 décembre 2003. Journal officiel du Cameroun, numéro 1; janvier 2004.